Jacobio Pharmaceuticals Group Co., Ltd. (1167.HK) Income Statement 2018 — 2022

Select a metric from the list below to chart it

Dec '18

Dec '19

Dec '20

Dec '21

Dec '22

Income Statement	Dec '18	Dec '19	Dec '20	Dec '21	Dec '22
Revenue	—	—	70.8	22.3	13.9
Revenue % Chg.	—	—	—	-68.6%	-37.3%
Cost of Revenue	—	—	6.4	20.4	12.1
Gross Profit	—	—	64.4	1.9	1.8
Gross Profit Margin	—	—	90.9%	8.4%	13.2%
R&D Expenses	12.4	20.2	27.1	40.9	64.9
Selling, General, & Admin Expenses	0.9	0.4	7.8	2.5	6.2
Other Expenses	—	8.5	-1.0	2.5	-0.1
Operating Income	-15.3	-28.3	26.1	-44.0	-69.1
Operating Income Margin	—	—	36.8%	-197.8%	-495.8%
Total Other Income/Expenses Net	-7.4	-33.7	-246.6	0.2	15.0
Income Before Tax	-22.7	-62.0	-220.5	-43.9	-54.2
Income Before Tax Margin	—	—	-311.3%	-197.1%	-388.4%
Income Tax Expense	—	34.2	246.7	-0.2	0.4
Net Income	-21.7	-96.2	-467.2	-43.7	-54.6
Net Income Margin	—	—	-659.6%	-196.4%	-391.5%
Weighted Avg. Shares Out	759.7	759.7	381.0	747.3	751.9
EPS	-0.0	-0.1	-1.2	-0.1	-0.1
EPS % Chg.	—	342.9%	867.8%	95.2%	25.0%
Weighted Avg. Shares Out Dil	759.7	759.7	381.0	747.3	751.9
EPS Diluted	-0.0	-0.1	-1.2	-0.1	-0.1
Interest Income	—	0.8	0.5	2.7	3.6
Interest Expense	0.3	0.2	0.2	0.1	0.3
EBIT	-23.0	-61.4	-220.2	-41.2	-50.9
EBIT Margin	—	—	-310.9%	-185.2%	-365.1%
Depreciation & Amortization	1.2	2.7	1.5	0.4	17.8
EBITDA	-21.8	-58.7	-218.7	-40.8	-33.1
EBITDA Margin	—	—	-308.7%	-183.2%	-237.7%

Jacobio Pharmaceuticals Group Co., Ltd. (1167.HK)